Concepedia

Five-Year Outcomes of Ranibizumab With Prompt or Deferred Laser Versus Laser or Triamcinolone Plus Deferred Ranibizumab for Diabetic Macular Edema

Susan B. Bressler, Adam R. Glassman, Talat Almukhtar, Neil M. Bressler, Frederick L. Ferris, Joseph M. Googe, Shailesh Kumar Gupta, Lee M. Jampol, Michele Melia, John A. Wells

American Journal of Ophthalmology · 2016 · 141 citations · 5 references

DOIFull text

Open access

Concepts

References

5

Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema

Michael J. Elman, Lloyd Paul Aiello, Roy W. Beck et al. · Ophthalmology · 2010 · 1.4K citations · Full text

, , +13

Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III Trials

David M. Brown, Quan Dong Nguyen, Dennis M. Marcus et al. · Ophthalmology · 2013 · 821 citations · Full text

, , +17

Expanded 2-Year Follow-up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema

Michael J. Elman, Neil M. Bressler, Haijing Qin et al. · Ophthalmology · 2011 · 571 citations · Full text

, , +14

Intravitreal Ranibizumab for Diabetic Macular Edema with Prompt versus Deferred Laser Treatment: 5-Year Randomized Trial Results

Michael J. Elman, Allison R. Ayala, Neil M. Bressler et al. · Ophthalmology · 2014 · 566 citations

, , +13

Three-Year Outcomes of Individualized Ranibizumab Treatment in Patients with Diabetic Macular Edema

Ursula Schmidt‐Erfurth, Gabriele E. Lang, Frank G. Holz et al. · Ophthalmology · 2014 · 314 citations · Full text

, , +17